Yu Yong Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$10,000.00
Insider Sells Quantity
14
Insider Sells Sum
$3.21M

Insider Activity of Yu Yong

According to the SEC Form 4 filings, Yu Yong, being in a position of

  1. Chief Scientific Officer at Genelux Corporation,
    оver the last 12 months, has bought 0 shares, and sold 12820 shares for $37,796,
    over all time since 2023-08-18, has bought 2500 shares for $10,000, and sold 219467 shares for $3.27M.

Biography of Yu Yong

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $37,7965100

Comparison of Insiders on Amount of Buys and Sells

2026-08-31SaleGenelux Corporation
GNLX
Chief Scientific Officer
9,683
0.0226%
$2.75$26,658-4.96%
2026-08-04SaleGenelux Corporation
GNLX
Chief Scientific Officer
653
0.0015%
$2.94$1,922-10.46%
2026-05-11SaleGenelux Corporation
GNLX
Chief Scientific Officer
605
0.0016%
$2.97$1,798-5.69%
2026-03-24SaleGenelux Corporation
GNLX
SVP, Clinical Development
906
0.0024%
$2.42$2,193+11.57%
2025-11-17SaleGenelux Corporation
GNLX
SVP, Clinical Development
973
0.0026%
$5.37$5,224-47.81%
2025-08-21SaleGenelux Corporation
GNLX
SVP, Clinical Development
3,219
0.0083%
$3.36$10,807-13.95%
2025-05-12SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
5,579
0.0155%
$2.92$16,291+14.75%
2024-06-24SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
6,849
0.0185%
$2.12$14,520+12.06%
2024-05-29PurchaseGenelux Corporation
GNLX
VP, Clinical Trial Operations
2,500
0.0105%
$4.00$10,000-9.29%
2023-12-15SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
32,535
0.1265%
$13.16$428,180-77.63%
2023-12-07SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
36,800
0.1379%
$11.85$435,995-75.44%
2023-11-21SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
18,665
0.0713%
$10.26$191,555-69.03%
2023-11-20SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
14,594
0.0592%
$11.26$164,261-69.68%
2023-11-17SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
3,541
0.0148%
$13.04$46,170-71.99%
2023-10-24SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
5,200
0.0193%
$19.11$99,351-80.52%
2023-10-10SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
5,200
0.0184%
$22.01$114,462-79.12%
2023-09-26SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
5,200
0.021%
$23.56$122,528-73.71%
2023-09-20SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
6,000
0.0223%
$27.96$167,786-78.75%
2023-09-15SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
10,400
0.0385%
$21.89$227,630-72.38%
2023-09-13SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
29,800
0.1061%
$21.14$629,927-70.18%
Total: 22
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.